| Commonwealth Clinical Group, Inc. | |
|
41 E Orange St Lancaster PA 17602-2846 | |
| (717) 393-3900 | |
| (717) 393-7900 |
| Full Name | Commonwealth Clinical Group, Inc. |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 41 E Orange St, Lancaster, Pennsylvania |
| Authorized Official Name and Position | Stacie Basham (BILLING COORDINATOR) |
| Authorized Official Contact | 7173933900 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Commonwealth Clinical Group, Inc. 41 E Orange St Lancaster PA 17602-2846 Ph: (717) 393-3900 | Commonwealth Clinical Group, Inc. 41 E Orange St Lancaster PA 17602-2846 Ph: (717) 393-3900 |
| NPI Number | 1023267473 |
|---|---|
| Provider Enumeration Date | 09/10/2008 |
| Last Update Date | 09/15/2021 |
| Certification Date | 09/15/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023267473 | NPI | - | NPPES |
| 1022334430003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
VitaPath Genetics, a molecular diagnostics company, announced today that it has closed a $6 million series A round of funding led by MDV-Mohr Davidow Ventures. VitaPath was originally seeded by X/Seed Capital, which also co-invested in the Series A. Concurrent with the financing MDV's Michael Goldberg and X/Seed's Michael Borrus took seats on the company's board.
Neovasc Inc. is pleased to announce the closing of its previously announced underwritten public offering of 12,075,000 common shares of the Company at a price per share of US$7.19 (the "Offering") for aggregate gross proceeds of approximately US$74,883,850 for the Company and US$11,935,400 for the Selling Securityholders (as defined below) before deducting underwriting discounts and commissions and offering expenses payable by the Company and the Selling Securityholders.
A new analysis of UK workers reveals that certain occupations may increase the risk of bladder cancer.
› Verified 8 days ago
Behavioral Health Solutions Of Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 922 W Fairway Dr, Lancaster, PA 17603 Phone: 717-723-8165 | |
Nuestra Clinica Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 545 Pershing Ave, Lancaster, PA 17602 Phone: 717-293-4150 Fax: 717-399-4289 | |
First Church Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 29 E Walnut St, Lancaster, PA 17602 Phone: 717-329-4178 Fax: 717-533-6071 | |
Above And Beyond Counseling Services Of Pa, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1655 Manheim Pike, Suite Ob4, Lancaster, PA 17601 Phone: 973-239-0948 Fax: 973-239-0972 | |
Thirty-nine West Vine Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 39 W Vine St, Lancaster, PA 17603 Phone: 717-394-5496 Fax: 717-533-6071 | |
Living Fully, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1771 Wilderness Rd, Lancaster, PA 17603 Phone: 717-862-8812 |